These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21444132)

  • 1. Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and σ receptor antagonists.
    Utech T; Köhler J; Wünsch B
    Eur J Med Chem; 2011 Jun; 46(6):2157-69. PubMed ID: 21444132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol.
    Aepkers M; Wünsch B
    Bioorg Med Chem; 2005 Dec; 13(24):6836-49. PubMed ID: 16169732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-based σ
    Asare-Nkansah S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2017 Apr; 25(8):2472-2481. PubMed ID: 28320613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of a potent and selective σ1 receptor antagonist with high antiallodynic activity.
    Utech T; Köhler J; Buschmann H; Holenz J; Vela JM; Wünsch B
    Arch Pharm (Weinheim); 2011 Jul; 344(7):415-21. PubMed ID: 21598296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
    Bonifazi A; Del Bello F; Mammoli V; Piergentili A; Petrelli R; Cimarelli C; Pellei M; Schepmann D; Wünsch B; Barocelli E; Bertoni S; Flammini L; Amantini C; Nabissi M; Santoni G; Vistoli G; Quaglia W
    J Med Chem; 2015 Nov; 58(21):8601-15. PubMed ID: 26430967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ₁ receptor ligands.
    Köhler J; Bergander K; Fabian J; Schepmann D; Wünsch B
    J Med Chem; 2012 Oct; 55(20):8953-7. PubMed ID: 23013229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and NMDA-receptor affinity of ring and side chain homologous dexoxadrol derivatives.
    Aepkers M; Wünsch B
    Arch Pharm (Weinheim); 2004 Feb; 337(2):67-75. PubMed ID: 14981662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between the structure of dexoxadrol and etoxadrol analogues and their NMDA receptor affinity.
    Sax M; Wünsch B
    Curr Top Med Chem; 2006; 6(7):723-32. PubMed ID: 16719812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists.
    Banerjee A; Schepmann D; Köhler J; Würthwein EU; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):7855-67. PubMed ID: 20965735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
    Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
    Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective synthesis and receptor binding of conformationally restricted and flexible 2,4-disubstituted 1,3-dioxanes derived from benzomorphans.
    Wünsch B; Bauschke G; Diekmann H; Höfner G
    Arch Pharm (Weinheim); 1999 Dec; 332(12):413-21. PubMed ID: 10634091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral, nonracemic (piperazin-2-yl)methanol derivatives with sigma-receptor affinity.
    Bedürftig S; Wünsch B
    Bioorg Med Chem; 2004 Jun; 12(12):3299-311. PubMed ID: 15158798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
    Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    ChemMedChem; 2010 May; 5(5):687-95. PubMed ID: 20340125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel σ
    Kopp N; Holtschulte C; Börgel F; Lehmkuhl K; Friedland K; Civenni G; Laurini E; Catapano CV; Pricl S; Humpf HU; Schepmann D; Wünsch B
    Eur J Med Chem; 2021 Jan; 210():112950. PubMed ID: 33148494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of bridged piperazines with sigma receptor affinity.
    Weigl M; Wünsch B
    Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.